Mala T, Abelseth BK, Al-Haidari G, Dørum LMR, Hatlevoll I, Rekstad LC, Stenvold H, Øvrebø KK, Aahlin EK(2024) [Not Available] Tidsskr Nor Laegeforen, 144(15) DOI 10.4045/tidsskr.24.0547, PubMed 39692659
Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Lordick Obermannová R, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Buges Sanchez C, Chau I, Lorenzen S, Daum S, Sinn M, Merelli Bet al.(2024) Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study Ann Oncol(in press) DOI 10.1016/j.annonc.2024.10.829, PubMed 39542422
Willmann J, Balermpas P, Rimner A, Appelt AL, Vasquez Osorio EM, Rønde HS, Day M, Embring A, Gabryś D, Guren MG, Hoskin P, Massaccesi M, Mayo C, Murray L, Nieder C, Guckenberger M, Andratschke N(2024) Ongoing prospective studies on reirradiation: A systematic review of a clinical trials database Radiother Oncol, 202, 110624(in press) DOI 10.1016/j.radonc.2024.110624, PubMed 39532233